The effect of resveratrol on advanced glycation end products in diabetes mellitus: a systematic review
- 3 March 2020
- journal article
- review article
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 128 (1) , 253-260
Abstract
Advanced glycation end products (AGEs) lead to chronic oxidative stress and inflammation, which in turn augment diabetes complications. Resveratrol plays a potential role in relation to diabetes due to improving of hyperglycemia, oxidative stress, and inflammation. The aim of this review was to evaluate the scientific literature to identify the impacts of resveratrol on the accumulation of AGEs. The literature was searched in the online databases, viz. PubMed, SCOPUS, Embase, ProQuest, and Google Scholar until May 2019. From a total of 338 retrieved articles, 10 papers were eligible for the present analysis. Except one clinical trial, all studies were conducted on animals. All the included studies, except one, showed inhibitory effects of resveratrol on the accumulation of AGE or receptor for AGEs. The findings indicate that resveratrol is a potential protective agent against the accumulation of AGEs. There is, however, the need for future studies to investigate this effect on human.Keywords
This publication has 79 references indexed in Scilit:
- The molecular mechanisms of pancreatic β-cell glucotoxicity: Recent findings and future research directionsMolecular and Cellular Endocrinology, 2012
- Nrf2 Represses FGF21 During Long-Term High-Fat Diet–Induced Obesity in MiceDiabetes, 2011
- Dietary Polyphenols and ObesityNutrients, 2010
- Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activationBiochemical and Biophysical Research Communications, 2009
- PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditureCurrent Opinion in Lipidology, 2009
- Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and InflammationCell Metabolism, 2009
- Resveratrol enhances GLUT‐4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardiumJournal of Cellular and Molecular Medicine, 2008
- Resveratrol potently reduces prostaglandin E2production and free radical formation in lipopolysaccharide-activated primary rat microgliaJournal of Neuroinflammation, 2007
- AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1αProceedings of the National Academy of Sciences of the United States of America, 2007
- Toxicogenomics of resveratrol in rat liverLife Sciences, 2005